Page results
-
This page has been written to answer some common questions about Tofersen treatment for patients, as well as their caregivers and families.
-
This service is unique in the UK, offering an adolescent rheumatology service that provides diagnostic and therapeutic advice to patients with any rheumatic diseases that occur in adolescence.
-
Periodontology is the management of patients with disorders of the gums and the supporting structures including teeth.
-
Restoritive dentistry services include periodontology, endodontics and orthodontics
-
Our Proton Beam Therapy (PBT) department can treat up to 650 NHS patients per year from across the south of the UK when we are at full capacity. We provide treatment for a wide range of child and teenage cancers and complex adult cancers.
-
The oesophageal and stomach surgery service works very closely with the specialist Upper Gastrointestinal (GI) service, gastroenterology, nutrition, oncology and radiology departments at UCLH. It comprises UCLH-based and Barts Health-based surgeons.
-
Having proton beam therapy: information for children aged 5-8 patient information page.
-
Having proton beam therapy: information for children aged 9-12 patient information
-
Having proton beam therapy: information for teenagers aged 13-17 patient information.
-
Our thoracic/respiratory medicine service offers a comprehensive inpatient and outpatient medical service for adults with conditions affecting the lungs.
File results
-
FOI/2022/0499 - Framework/ tender for services used to collect offensive and clinical waste
-
FOI/2022/0505 - Type of needles used for insulin administration to patients
-
FOI/2022/0515 - Senior staff contact details
-
FOI/2022/0536 - Head of Procurement contact details
-
FOI/2022/0551 - Procurement contact details
-
FOI/2022/0555 - Senior staff contact details
-
FOI/2022/0563 - Ambulatory cardiac monitoring
-
FOI/2022/0542 - Infection control audits from September 2020 to April 2021
-
FOI/2022/0544 - Wards/ departments that provide services to 0-17 year-olds
-
FOI/2022/0548 - Biologic and biosimilar products within Rheumatology